Paper32272076
Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?
Klasse PJ and 3 others. Cell Host Microbe, 2020. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens? Papers, record 32272076. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32272076
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV Antibodies | Major topic |
| HIV-1 | Major topic |
| env Gene Products, Human Immunodeficiency Virus | Major topic |
| AIDS Vaccines | |
| Adaptive Immunity | |
| Antibodies, Neutralizing | |
| B-Lymphocytes | |
| CD4 Antigens | |
| Epitopes, B-Lymphocyte | |
| Immunity, Innate | |
| Mannose | |
| Membrane Glycoproteins | |
| Molecular Mimicry | |
| Protein Binding | |
| Protein Multimerization | |
| T-Lymphocytes |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P01 AI110657 | NIAID NIH HHS | United States | P01AI110657 | PubMed and NIH |
Source NIH RePORTER
References155
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30971821 | Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET. | Nature | 2019 | https://conductscience.org/library/papers/30971821 | PubMed |
| 2 | 29162799 | Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding. | Nat Commun | 2017 | https://conductscience.org/library/papers/29162799 | PubMed |
| 3 | 31097697 | Kappa chain maturation helps drive rapid development of an infant HIV-1 broadly neutralizing antibody lineage. | Nat Commun | 2019 | https://conductscience.org/library/papers/31097697 | PubMed |
| 4 | 29220496 | Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies. | J Infect Dis | 2018 | https://conductscience.org/library/papers/29220496 | PubMed |
| 5 | 30190230 | When designing vaccines, consider the starting material: the human B cell repertoire. | Curr Opin Immunol | 2018 | https://conductscience.org/library/papers/30190230 | PubMed |
| 6 | 12193713 | Role of disulfide bonds in regulating antigen processing and epitope selection. | J Immunol | 2002 | https://conductscience.org/library/papers/12193713 | PubMed |
| 7 | 31271322 | Novel prime-boost vaccine strategies against HIV-1. | Expert Rev Vaccines | 2019 | https://conductscience.org/library/papers/31271322 | PubMed |
| 8 | 12804865 | Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin. | Vaccine | 2003 | https://conductscience.org/library/papers/12804865 | PubMed |
| 9 | 29794117 | Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity. | J Exp Med | 2018 | https://conductscience.org/library/papers/29794117 | PubMed |
| 10 | 27843002 | Comparison of the patterns of antibody recall responses to HIV-1 gp120 and hepatitis B surface antigen in immunized mice. | Vaccine | 2016 | https://conductscience.org/library/papers/27843002 | PubMed |
| 11 | 25349379 | Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25349379 | PubMed |
| 12 | 23700434 | Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cells. | PLoS One | 2013 | https://conductscience.org/library/papers/23700434 | PubMed |
| 13 | 7903129 | Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein. | Virology | 1994 | https://conductscience.org/library/papers/7903129 | PubMed |
| 14 | 25681373 | Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/25681373 | PubMed |
| 15 | 28847869 | Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo. | J Exp Med | 2017 | https://conductscience.org/library/papers/28847869 | PubMed |
| 16 | 26491081 | Immune correlates of vaccine protection against HIV-1 acquisition. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/26491081 | PubMed |
| 17 | 21762802 | HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. | J Mol Biol | 2011 | https://conductscience.org/library/papers/21762802 | PubMed |
| 18 | 10716904 | Helper T-cell epitope immunodominance associated with structurally stable segments of hen egg lysozyme and HIV gp120. | J Theor Biol | 2000 | https://conductscience.org/library/papers/10716904 | PubMed |
| 19 | 27309817 | Design of a hyperstable 60-subunit protein dodecahedron. [corrected]. | Nature | 2016 | https://conductscience.org/library/papers/27309817 | PubMed |
| 20 | 28539451 | Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers. | J Virol | 2017 | https://conductscience.org/library/papers/28539451 | PubMed |
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42931443 | Advances in HIV-1 Envelope-Based Vaccine Development. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42931443 | PubMed |
| 41959402 | Decoding epitope immunodominance in HIV Env using cryoEM and machine learning. | bioRxiv | 2026 | https://conductscience.org/library/papers/41959402 | PubMed |
| 41373539 | Under the Radar: Immune Evasion, Pathogenesis and Control of HIV Infection. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373539 | PubMed |
| 41334187 | Beyond monotherapy: Combination therapies for HIV-1 cure through joint application of neutralizing antibodies, genome editing, and reservoir management. | Infect Med (Beijing) | 2025 | https://conductscience.org/library/papers/41334187 | PubMed |
| 41112192 | Bridging Viral Glycobiology and Lectin Biotechnology for Antiviral and Diagnostic Strategies. | ACS Bio Med Chem Au | 2025 | https://conductscience.org/library/papers/41112192 | PubMed |
| 40835839 | Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/40835839 | PubMed |
| 40708523 | Unveiling an Immunological Mystery: Deciphering the Durability Divide in Vaccine-Elicited Antibody Responses. | Curr HIV Res | 2026 | https://conductscience.org/library/papers/40708523 | PubMed |
| 40702326 | The HIV-1 envelope glycoprotein: structure, function and interactions with neutralizing antibodies. | Nat Rev Microbiol | 2025 | https://conductscience.org/library/papers/40702326 | PubMed |
| 40461490 | Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody response. | Nat Commun | 2025 | https://conductscience.org/library/papers/40461490 | PubMed |
| 39651156 | Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques. | bioRxiv | 2025 | https://conductscience.org/library/papers/39651156 | PubMed |
| 39372389 | Clinical glycoproteomics: methods and diseases. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/39372389 | PubMed |
| 39361585 | Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopes. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/39361585 | PubMed |
| 39303017 | Two-dose priming immunization amplifies humoral immunity by synchronizing vaccine delivery with the germinal center response. | Sci Immunol | 2024 | https://conductscience.org/library/papers/39303017 | PubMed |
| 38628675 | The Question of HIV Vaccine: Why Is a Solution Not Yet Available? | J Immunol Res | 2024 | https://conductscience.org/library/papers/38628675 | PubMed |
| 37903160 | Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization. | PLoS Pathog | 2023 | https://conductscience.org/library/papers/37903160 | PubMed |
| 37244989 | Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization. | Retrovirology | 2023 | https://conductscience.org/library/papers/37244989 | PubMed |
| 37044090 | Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions. | Cell Rep Med | 2023 | https://conductscience.org/library/papers/37044090 | PubMed |
| 37031217 | Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimmers as HIV-1 vaccine candidates. | Nat Commun | 2023 | https://conductscience.org/library/papers/37031217 | PubMed |
| 37014912 | Essential role of an ERV-derived Env38 protein in adaptive humoral immunity against an exogenous SVCV infection in a zebrafish model. | PLoS Pathog | 2023 | https://conductscience.org/library/papers/37014912 | PubMed |
| 36255672 | Synthesis, Processing, and Function of N-Glycans in N-Glycoproteins. | Adv Neurobiol | 2023 | https://conductscience.org/library/papers/36255672 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32272076
GET https://conductscience.org/api/papers/v1/32272076/references?page=2